Andrew Charles Perkins (Andrew C Perkins, Andrew Perkins)

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Venues

EJHaem

Nature communications

British journal of haematology

Transfusion

Alfred Hospital

University of Melbourne (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alfred Hospital Nov 01 2017

Australia

Molecular Pathologist :: Pathology

Monash University Jul 07 2017

Australia

Professor of Blood Cancer Genomics :: Australian Centre for Blood Diseases

Alfred Health Jul 03 2017

Australia

Professor :: Clinical Haematology

University of Queensland Jul 01 2017

Australia

Honorary Professor :: Medicine and Biomedical Sciences

University of Queensland - Jul 10 2017

Australia

Senior Principal Research Fellow :: Mater Research UQ

Mater Misericordiae Health Services Brisbane Ltd - Jul 10 2017

Australia

Principal Research Fellow :: Mater Medical Research Insitute

Queensland Health - Jul 05 2017

Australia

Senior Medical Officer :: Cancer Services

Mater Misericordiae Health Services Brisbane Ltd - Mar 14 2017

Australia

Molecular and Haematological Pathologist :: Pathology

University of Queensland

Australia

Principal Research Fellow :: Institute for Molecular Bioscience

Monash University

Australia

Wellcome Trust Senior Research Fellow :: Physiology

Alfred Hospital

Australia

Staff Specialist (part time) :: Haematology

Monash University

Australia

Logan Research Fellow :: Physiology

Royal Prince Alfred Hospital

Australia

Resident and Registrar :: Haematology

Harvard Medical School

United States

Leukemia Society of America Special Research Fellow :: Childrens Hospital

Harvard Medical School

United States

Lucille P Markey Postdoctoral Fellow :: Childrens Hospital

Royal Melbourne Hospital

Australia

Staff Specialist (part time) :: Haematology

Education History

University of Melbourne

Australia

PHD :: W.E.H.I. (Cancer Genetics)

University of Sydney

Australia

BSC :: Medicine

Publications

Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Radha Ramanan, James D McFadyen, Andrew Charles Perkins, Huyen A Tran
Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events-RESPONSE. British journal of haematology 204 (6) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Radha Ramanan, James D McFadyen, Andrew Charles Perkins, Huyen A Tran
Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events-RESPONSE. British journal of haematology (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Radha Ramanan, James D McFadyen, Andrew Charles Perkins, Huyen A Tran
Congenital fibrinogen disorders-Strengthening genotype-phenotype correlations through novel genetic diagnostic tools. British journal of haematology (2023)
Tomasz J Block, Cat Shore-Lorenti, Roger Zebaze, Peter G Kerr, Anna Kalff, Andrew Charles Perkins, Peter R Ebeling, Frances Milat
A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis. JBMR plus 7 (9) (2023)
Naveen Pemmaraju, Jacqueline S Garcia, Andrew Charles Perkins, Jason G Harb, Andrew J Souers, Michael E Werner, Christopher M Brown, Francesco Passamonti
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-X L /BCL-2 inhibition with navitoclax. Cancer (2023)
Jessica M Salmon, Izabela Todorovski, Kym L Stanley, Claudia Bruedigam, Conor J Kearney, Luciano G Martelotto, Fernando J Rossello, Timothy Semple, Gisela Mir Arnau, Magnus Zethoven, Michael Bots, Stefan Bjelosevic, Leonie A Cluse, Peter J Fraser, Veronique Litalien, Eva Vidacs, Kate McArthur, Antony Y Matthews, Elise Gressier, Nicole A de Weerd, Jens Lichte, Madison J Kelly, Simon J Hogg, Paul J Hertzog, Lev M Kats, Stephin J Vervoort, Daniel D De Carvalho, Stefanie Scheu, Sammy Bedoui, Benjamin T Kile, Steven W Lane, Andrew Charles Perkins, Andrew H Wei, Pilar M Dominguez, Ricky W Johnstone
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML. Cancer discovery 12 (6) (2022)
Wing Fuk Chan, Hannah D Coughlan, Yunshun Chen, Christine R Keenan, Aaron T L Lun, Andrew Charles Perkins, Timothy M Johanson, Rhys S Allan
Activation of stably silenced genes by recruitment of a synthetic de-methylating module. Nature communications 13 (1) (2022)
Srdan Verstovsek, Haifa Kathrin Al-Ali, John O Mascarenhas, Andrew Charles Perkins, Alessandro Maria Maria Vannucchi, Sanjay R Mohan, Bart L Scott, Dariusz Woszczyk, Steffen Koschmieder, Regina García-Delgado, Rejtő László, Jesse S McGreivy, Wayne P Rothbaum, Jean-Jacques Kiladjian
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis. Future oncology (London, England) (2022)
Steven Ngo, Ethan P Oxley, Margherita Ghisi, Maximilian M Garwood, Mark D McKenzie, Helen L Mitchell, Peter Kanellakis, Olivia Susanto, Michael J Hickey, Andrew Charles Perkins, Benjamin T Kile, Ross A Dickins
Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy. Nature communications 12 (1) (2021)
Srdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, Martin Ellis, Maria Laura Fox, Yeow T Goh, Vikas K Gupta, Claire Harrison, Jean-Jacques Kiladjian, Mihaela C Lazaroiu, Adam J Mead, Donal McLornan, Mary Frances Frances McMullin, Stephen T Oh, Andrew Charles Perkins, Uwe Platzbecker, Christof Scheid, Alessandro Maria Maria Vannucchi, Sung-Soo Yoon, Mark M Kowalski, Ruben A Mesa
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic. Future oncology (London, England) 17 (12) (2021)
Rhiannon Morris, Liesl Ann Butler, Andrew Charles Perkins, Nadia J Kershaw, Jeffrey J Babon
The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Kavita Bisht, Marion E Brunck, Taichi Matsumoto, Crystal McGirr, Bianca Nowlan, Whitney Fleming, Thomas Keech, Graham Magor, Andrew Charles Perkins, Julie Davies, Gail Walkinshaw, Lee Flippin, Ingrid G Winkler, Jean-Pierre Lévesque
HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR. Blood advances 3 (3) (2020)
Therese Vu, Jasmin Straube, Amy H Porter, Megan Bywater, Axia Song, Victoria Y Ling, Leanne Cooper, Gabor Pali, Claudia Bruedigam, Sebastien Jacquelin, Joanne Green, Graham Magor, Andrew Charles Perkins, Alistair M Chalk, Carl R Walkley, Florian H Heidel, Pamela Mukhopadhyay, Nicole Cloonan, Stefan Gröschel, Jan Philipp Mallm, Stefan Fröhling, Claudia Scholl, Steven W Lane
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia. Nature communications 11 (1) (2020)
Kevin Gillinder, Graham Magor, Andrew Charles Perkins
Variable serologic and other phenotypes due to KLF1 mutations. Transfusion 58 (5) (2018)
Nicole S Fraser, Christine M Knauth, Elizna M Schoeman, Assia Moussa, Andrew Charles Perkins, Terry Walsh, Glenda M Millard, Melinda M Dean, Catherine A Hyland, Robert L P Flower
Investigation of the variable In(Lu) phenotype caused by KLF1 variants. Transfusion 58 (10) (2018)
Hao Lu, Maria C Rondón Galeano, Elisabeth Ott, Geraldine Kaeslin, P Jaya Kausalya, Carina Kramer, Nadina Ortiz-Brüchle, Nadescha Hilger, Vicki Metzis, Milan Hiersche, Shang Yew Tay, Robert Tunningley, Shubha Vij, Andrew D Courtney, Belinda Whittle, Elke Wühl, Udo Vester, Björn Hartleben, Steffen Neuber, Valeska Frank, Melissa H Little, Daniel Epting, Peter Papathanasiou, Andrew Charles Perkins, Graham Daniel Wright, Walter Hunziker, Heon Yung Gee, Edgar A Otto, Klaus Zerres, Friedhelm Hildebrandt, Sudipto Roy, Carol Wicking, Carsten Bergmann
Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease. Nature genetics 49 (7) (2017)
Andrew Charles Perkins, Xiangmin Xu, Douglas R Higgs, George P Patrinos, Lionel Arnaud, James J Bieker, Sjaak Philipsen, null null
Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants. Blood 127 (15) (2016)

Andrew Charles Perkins.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew C Perkins, Andrew Perkins)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew Charles Perkins (Andrew C Perkins, Andrew Perkins)